| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 06/10/2004 | US20040110947 such as methyl-3-[([2-[(3-chloro-2,2-dimethylpropanoyl)amino]phenyl]thio)methyl]benzoate; lipid/lipoprotein metabolism |
| 06/10/2004 | US20040110946 such as ethyl-2-[6-amino-4-(1,3-benzodioxol-5-yl)-3,5-dicyano-2-pyridinyl]propionate; drug screening; for treatment of cardiovascular disorders/diabetes |
| 06/10/2004 | US20040110839 Compounds and compositions for delivering active agents |
| 06/10/2004 | US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 06/10/2004 | US20040110806 Dipeptide derivatives |
| 06/10/2004 | US20040110802 Antibacterial benzoic acid derivatives |
| 06/10/2004 | US20040110801 Prevention of degenerative joint diseases, rheumatoid arthritis, osteoarthritis, ulcerative colitis, irritable colon and Crohn's diseas, antitumor agents; drug mixture for transdermal drug delivery, sustained release; chemical synthesis |
| 06/10/2004 | US20040110768 (S)-3-(1H-indol-3-yl)-N-(1-methoxymethyl-cyclohexylmethyl)-2-methyl-2-[4-(4-nitro-phenyl)-oxazol-2-ylamino]-propionamide for example; cancer, psychological disorders, sexual disorders, eating disorders, inflammatory bowel disease, sleep disorders |
| 06/10/2004 | US20040110767 Acyclic amide and sulfonamide ligands for the estrogen receptor |
| 06/10/2004 | US20040110765 3-phenyl-N-{1-[3-(4-pyridin-2-yl-piperazin-1-yl)-phenyl]-ethyl}-acrylamide for example; migraine, neuropathic pain, convulsions, mania, epilepsy, anxiety, depression, bipolar disorder, and neurodegenerative disorders |
| 06/10/2004 | US20040110756 Anthracene-9-yl-[4-(4-nitro-phenyl)-piperazine-1-yl]-methanone for example; antitumor agents for benign and malignant tumors |
| 06/10/2004 | US20040110754 2-(2-fluoro-phenyl)-cyclopropanecarboxylic acid[1-(2,3-dihydro-benzofuran-5-yl)-ethyl]-amide for example; for pain, migraine, neuropathic pain, bipolar disorders, convulsions, mania, epilepsy, anxiety, depression and neurodegenerative disorders |
| 06/10/2004 | US20040110753 Tyrosine derivatives |
| 06/10/2004 | US20040110748 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 06/10/2004 | US20040110737 Complex derivatives of bis(2-acetylpyridinethiosemicarbazonato-N1,N2,S)gallium(III) as anticarcinogenic agents |
| 06/10/2004 | US20040110730 Using salts of hydrazine and/or (thio)carbonylamino derivatives of hydrazine for conjugation and immobilization of biomolecules; diagnosis |
| 06/10/2004 | US20040110303 Artificial receptors, building blocks, and methods |
| 06/10/2004 | US20040110031 emits a blue light with high emission luminance, high quantum efficiency and long half life and a display employing the organic element |
| 06/10/2004 | US20040110009 Non-covalent assembly of multilayer thin film supramolecular structures |
| 06/10/2004 | US20040108507 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 06/10/2004 | CA2506895A1 Cannabinoid receptor ligands |
| 06/10/2004 | CA2505542A1 Mandelic acid derivatives |
| 06/10/2004 | CA2502156A1 Substituted pyridyloxyalkylamides and their use as fungicides |
| 06/09/2004 | EP1426360A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
| 06/09/2004 | EP1426046A1 Novel use of tricyclic compound |
| 06/09/2004 | EP1425287A1 Processes for preparing calcium salt forms of statins |
| 06/09/2004 | EP1425276A2 Heterocyclic carboxamides and their use as fungicides |
| 06/09/2004 | EP1425269A1 A process for the production of heteroaromatic nitriles, an improved catalyst therefor and a process for the production of said improved catalyst |
| 06/09/2004 | EP1425267A2 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments |
| 06/09/2004 | EP1425266A1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments |
| 06/09/2004 | EP1425262A1 Acylthiols and component thiol compositions as anti-hiv and anti-retroviral agents |
| 06/09/2004 | EP1425010A1 Substituted indoles and their use as integrin antagonists |
| 06/09/2004 | EP1425001A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/09/2004 | EP1186597B1 Process for the production of 2-pyridylpyridine derivatives |
| 06/09/2004 | EP1147162B1 Ferroelectric active matrix displays with wide operating temperature range |
| 06/09/2004 | DE10142667B4 C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel C2-substituted indan-1-ols and their derivatives, and their use as medicaments |
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1503774A Carboxylic acid derivative and thereof |
| 06/09/2004 | CN1503696A Complex catalyst process for producing the complex catalyst and process for producing alcohol derivative with the complex catalyst |
| 06/09/2004 | CN1503684A Use of nk-1 receptor antagonists against benign prostatic hyperplasia |
| 06/09/2004 | CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/09/2004 | CN1502610A Processes for preparing pesticidal intermediates |
| 06/09/2004 | CN1502608A Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity |
| 06/09/2004 | CN1502607A Aromatic tetramine compound containing pyridine structure and preparation method and use thereof |
| 06/09/2004 | CN1152872C Method for preparing 4-(3-pyridinyl)-1H-imidazole and the inter medicates used |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/09/2004 | CN1152863C Substituted pyridines as selective coclooxygenase-2-inhibitors and composition thereof |
| 06/09/2004 | CN1152862C Pyridine base synthesis |
| 06/08/2004 | US6747152 Catalytic compositions and methods for asymmetric allylic alkylation |
| 06/08/2004 | US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication |
| 06/08/2004 | US6747149 Glucamine salts for treating hepatitis virus infections |
| 06/08/2004 | US6747146 Method of producing nitroguanidine- and nitroenamine derivatives |
| 06/08/2004 | US6747053 Heteroaryl nitriles |
| 06/08/2004 | US6747048 Pyridine-based thyroid receptor ligands |
| 06/08/2004 | US6747047 Arthropodicides |
| 06/08/2004 | US6747042 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 06/08/2004 | US6747041 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same |
| 06/08/2004 | US6747040 Imidazonaphthyridines |
| 06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
| 06/08/2004 | US6747027 Selectively inhibits in vitro activity of human matrix metalloprotease-13 over in vitro activity of human matrix metalloprotease-1 |
| 06/08/2004 | US6747026 NK-1 receptor active amine oxide prodrugs |
| 06/08/2004 | US6747023 Sulfonyl derivatives |
| 06/08/2004 | US6747009 Peptidomimetic glutathione analogs |
| 06/08/2004 | US6746989 Substituted benzoylpyrazoles as herbicides |
| 06/08/2004 | US6746731 Ferroelectric active matrix displays with wide operating temperature range |
| 06/08/2004 | US6746728 Superior liquid crystallinity and co-solubility with currently used liquid crystal compounds; temperature range over which liquid crystallinity is shown is broad; threshold voltage is low; capable of high speed response |
| 06/08/2004 | CA2307552C Substituted pyridine compounds as anti-inflammatory agents |
| 06/08/2004 | CA2102490C 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them |
| 06/03/2004 | WO2004046324A2 Allele-targeted rna interference |
| 06/03/2004 | WO2004046119A1 Substituted aralkyl derivatives |
| 06/03/2004 | WO2004046114A1 Novel process for the preparation of 2-aminomethylpyridine derivative |
| 06/03/2004 | WO2004046113A2 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors |
| 06/03/2004 | WO2004046103A2 Arylpyridine compounds |
| 06/03/2004 | WO2004046096A2 Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 06/03/2004 | WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 06/03/2004 | WO2004046092A2 Aryl sulfonamides |
| 06/03/2004 | WO2004046091A2 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/03/2004 | WO2004046090A2 Aryl ureido derivatives and their medical use |
| 06/03/2004 | WO2004046066A1 Method for deuteration or tritiation of heterocyclic ring |
| 06/03/2004 | WO2004045610A1 Aminoalcohol derivatives and their use as beta-3 adrenergic receptor agonists |
| 06/03/2004 | WO2004033418A3 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | US20040106830 Method of synthesizing camptothecin-relating compounds |
| 06/03/2004 | US20040106801 quaternizing pyridine with a quaternizing agent, isolating the resulting salt and aminating the salt, N-[4-pyridyl] pyridinium chloride hydrochloride, with N,N-dimethyl formamide, performing solvent extraction, distilling the extracted organic mass |
| 06/03/2004 | US20040106796 cyclization of a 3-amidyl-4-amino-pyrazole compound with n-hydroxy-5-[(4-methylpiperazin-1-yl)sulfonyl]benzenecarboximidamidine compound; anti-impotency drugs |
| 06/03/2004 | US20040106795 Peptide deformylase inhibitors |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106792 Biphenyl compound |
| 06/03/2004 | US20040106679 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 06/03/2004 | US20040106675 class of compounds generally called the "statins" for use in stimulating bone formation and method to identify compounds useful in this regard by assessing their ability to inhibit enzymes in the pathway of isoprenoid synthesis |
| 06/03/2004 | US20040106653 Aminoalcohol derivatives |
| 06/03/2004 | US20040106651 3,4-diaminopyriding tartrate and phosphate, pharmaceutical compositions and uses thereof |
| 06/03/2004 | US20040106648 dioxodihydropyridine derivatives; 2-acyloxy-5-acylaminofuran and acylvinylene imide intermediates; especially tumour growth inhibitors and anti-cancer agents, antibiotics and/or antiviral agents |
| 06/03/2004 | US20040106633 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/03/2004 | US20040106626 amidine containing compounds which inhibit serine proteases |
| 06/03/2004 | US20040106625 Therapeutic agents useful for treating pain |
| 06/03/2004 | US20040106621 3-Heterocyclic benzylamide derivatives as potassium channel openers |
| 06/03/2004 | US20040106615 For treating or lessening the severity of a variety of disorders, including stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant |
| 06/03/2004 | US20040106611 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 06/03/2004 | US20040106606 Dihydropyrones with tethered heterocycles |